CATX

Stock ticker: ASE

PRICE

CHANGE

CAPITALIZATION

Perspective Therapeutics (CATX) Earnings Date & Reports

Industry: @Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

CATX is expected to report earnings to rise 26.67% to -26 cents per share on March 27

Perspective Therapeutics CATX Stock Earnings Reports

Q4'24

Est.

$-0.27

Q3'24

Est.

$-0.21

Q2'24

Missed

by $0.16

Q1'24

Est.

$-0.02

Q4'23

Missed

by $0.03

The last earnings report on November 12 showed earnings per share of -20 cents, meeting the estimate of -20 cents. With 1.31M shares outstanding, the current market capitalization sits at 751.25M.

View a ticker or compare two or three

Compare

CATX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For CATX
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a producer of therapeutic radioactive isotopes

Industry MedicalSpecialties

Profile

Fundamentals

Details

Industry

Biotechnology

Address

2401 Elliott Avenue

Phone

+1 206 676-0900

Employees

119

Web

https://www.perspectivetherapeutics.com